Startup · United Kingdom
Portal Biotech
Updated HQ London, United KingdomFounded 202111-50 employees
Single-molecule protein sequencing for medicine and biosecurity.
Funding1 round · ~$36.6M
- Equity raised
- ~$36.6M
- Latest
- ~$36.6MSeries A · Jun 30, 2025
| Announced | Stage | Amount | Valuation | Lead investors | Other investors | Confidence |
|---|---|---|---|---|---|---|
| Jun 30, 2025 | Series A | ~$36.6M | — | NATO Innovation Fund | — | Reported |
- Series ALed by NATO Innovation Fund~$36.6MJun 30, 2025
Raised counts equity rounds; debt, secondary sales and grants are totaled separately. Amounts in other currencies are converted at the announcement month's average rate. A ~ marks an estimated or converted amount.
Capabilities2
| Technology | Role | Maturity | TRL | Notes | Confidence |
|---|---|---|---|---|---|
| Biotechnology and biomanufacturing | Developer | — | — | Run 97, reviewed AI classification, taxonomy 2026-10-18b: Reputable report says Portal's single-molecule protein sequencing detects engineered threats, is NATO Innovation Fund-backed, and is also used for medicine. Source: https://thedefensepost.com/2025/07/02/nato-fund-portal-biotech/ | Reported |
| CBRN defense and security screening | Developer | — | — | Run 97, reviewed AI classification, taxonomy 2026-10-18b: Reputable report says Portal's single-molecule protein sequencing detects engineered threats, is NATO Innovation Fund-backed, and is also used for medicine. Source: https://thedefensepost.com/2025/07/02/nato-fund-portal-biotech/ | Reported |
- DeveloperRun 97, reviewed AI classification, taxonomy 2026-10-18b: Reputable report says Portal's single-molecule protein sequencing detects engineered threats, is NATO Innovation Fund-backed, and is also used for medicine. Source: https://thedefensepost.com/2025/07/02/nato-fund-portal-biotech/—Reported
- DeveloperRun 97, reviewed AI classification, taxonomy 2026-10-18b: Reputable report says Portal's single-molecule protein sequencing detects engineered threats, is NATO Innovation Fund-backed, and is also used for medicine. Source: https://thedefensepost.com/2025/07/02/nato-fund-portal-biotech/—Reported
Maturity and TRL describe this organization's work; the field-wide maturity is on each technology's page.
People3
| Person | Role |
|---|---|
| Andy Heron | Co-Founder & CEO |
| Giovanni Maglia | Co-Founder & CSO |
| Selly Saini | COO |
Sources7
Profile4
- 1
- 2
thedefensepost.com · Supports Organization · sector classification
“Portal Biotech utilizes AI-backed technology combined with biological sensors capable of single-molecule protein sequencing to detect engineered threats.”
- 3DatabasePortal Biotech — hq city
Supports Organization · country, Organization · hq city
“Location:London,England,United Kingdom”
- 4CompanyPortfolio
NATO Innovation Fund · Supports Organization
“Portal Biotech is a pioneering biotechnology company”
Funding1
- 5CompanyPortal Biotech | LinkedIn
LinkedIn · Supports Funding round, Organization · employee range, Organization · ownership, Role
“funding round: Series A, 2025-06-30, GBP 27,000,000, lead: Earlybird Venture Capital;NATO Innovation Fund”
People2
- 6
Portal Biotech · Supports Organization · website, Role
“Portal Biotech | Single-molecule proteomics”
- 7
University of Groningen · Supports Role
“Portal Biotech builds on the ideas of Prof. Giovanni Maglia from the Groningen Biomolecular Sciences and Biotechnology Institute (GBB) at the University of Groningen Faculty of Science and Engineering.”
Each fact on this page is attached to the sources that support it. Archived copies are linked when we keep one.